Ontario Pharmacists and Avricore Health Partner to Expand HealthTab™ in Community Pharmacies and Enhance Patient Care
November 18, 2019 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are...
Prevent Cancer Foundation® awards $250,000 in community grants
August 16, 2019 13:18 ET
|
Prevent Cancer Foundation
Alexandria, Va., Aug. 16, 2019 (GLOBE NEWSWIRE) -- Through its community grants program, the Prevent Cancer Foundation® is proud to support 10 projects focused on increasing cancer prevention and...
Think you’re “Too Young for This Sh*t?” Think again.
March 25, 2019 13:13 ET
|
Prevent Cancer Foundation
Alexandria, Va., March 25, 2019 (GLOBE NEWSWIRE) -- It’s a common misconception that colorectal cancer affects only older people—but today, more adults under the recommended screening age are being...
COMS Interactive Releases an Enhanced Design, Skilled Nursing Facilities Already Seeing Value
February 02, 2017 11:35 ET
|
COMS Interactive
BROADVIEW HEIGHTS, Ohio, Feb. 02, 2017 (GLOBE NEWSWIRE) -- COMS Interactive, the clinical care and quality improvement leader in the senior care market, released a new assessment design and...
DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference
July 21, 2016 08:30 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...
DiamiR Announces Oral Presentation at Biomarkers Summit 2016
March 18, 2016 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 18, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that...
Provista Diagnostics Announces the Closing of $6.0 Million Financing
August 04, 2015 15:20 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, Aug. 4, 2015 (GLOBE NEWSWIRE) -- August 4, 2015: Provista Diagnostics, Inc., a privately held molecular diagnostics company headquartered in New York, today announced the closing of $6.0...
DiamiR Announces Presentation at Extracellular Biomarkers Summit 2015
March 11, 2015 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 11, 2015) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
November 17, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
November 03, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...